Literature DB >> 24837260

Effects of individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1.

Ravinea Manotheepan1, Jørg Saberniak2, Tore K Danielsen3, Thor Edvardsen2, Ivar Sjaastad3, Kristina H Haugaa2, Mathis K Stokke4.   

Abstract

Ventricular arrhythmias (VAs) in patients with catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) are triggered at an individual and reproducible heart rate (HR) during exercise. Long-term effects of exercise on arrhythmia threshold in CPVT1 are not known. To investigate whether exercise training (ET) is feasible in patients with CPVT1, 13 patients with CPVT1 and confirmed genetic mutations performed bicycle exercise testing with maximal oxygen uptake (VO2max) measurements at baseline and after 13 weeks. The threshold HR for VA was defined as the HR when bigeminal ventricular extrasystoles or more severe VAs occurred. Six patients were enrolled in a 12-week high-intensity ergometer bicycle ET program (ET patients) with 60 min exercise sessions 3 times per week. The remaining 7 patients with CPVT1 were included as "sedentary" control (SED) patients complying with current recommendations to restrain from high-intensity physical activity. ET patients completed 28 ± 3 exercise sessions (78 ± 8% program completion) with 13 ± 3% increase in VO2max versus baseline (20.2 ± 1.6 vs 17.9 ± 1.3 ml/kg/min, p <0.05). No adverse events occurred. Baseline threshold for VA was 100 ± 6 beats/min in ET patients and 135 ± 4 beats/min in SED patients. After the training period, threshold HR for VA was 111 ± 10 beats/min in ET patients and 123 ± 6 beats/min in SED patients. The threshold for VA increased in ET compared with SED patients (+11 vs -12 beats/min, p <0.05). In conclusion, patients with CPVT1 benefitted from individualized ET with improved aerobic capacity and increased threshold HR for VA compared with SED patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24837260     DOI: 10.1016/j.amjcard.2014.03.012

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.

Authors:  Ravinea Manotheepan; Tore K Danielsen; Mani Sadredini; Mark E Anderson; Cathrine R Carlson; Stephan E Lehnart; Ivar Sjaastad; Mathis K Stokke
Journal:  Cardiovasc Res       Date:  2016-05-08       Impact factor: 10.787

2.  Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice.

Authors:  Hsiang-Ting Ho; Senthil Thambidorai; Björn C Knollmann; George E Billman; Sandor Györke; Anuradha Kalyanasundaram
Journal:  Heart Rhythm       Date:  2017-10-10       Impact factor: 6.343

3.  Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation.

Authors:  Tore K Danielsen; Ravinea Manotheepan; Mani Sadredini; Ida S Leren; Andrew G Edwards; Kevin P Vincent; Stephan E Lehnart; Ole M Sejersted; Ivar Sjaastad; Kristina H Haugaa; Mathis K Stokke
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

Review 4.  Catecholaminergic polymorphic ventricular tachycardia: An exciting new era.

Authors:  Shashank P Behere; Steven N Weindling
Journal:  Ann Pediatr Cardiol       Date:  2016 May-Aug

5.  Cardiac Rehabilitation: Far Beyond Coronary Artery Disease.

Authors:  Claudio Gil Soares de Araújo
Journal:  Arq Bras Cardiol       Date:  2015-12       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.